Evidence map›Paper›PMID 41046072›Full record

ArticleVirologica Sinica2025

Phylogenomics and structural modelling feature accelerated evolution of Oropouche virus: 1955 to 2024.

Yibo Ding, Jiajing Li, Xin Wang, Simone Malagò, Amaro Nunes Duarte-Neto, Xiaohui Ding, Fang Qin, Michela Deiana, Concetta Castilletti, Hongbo Guo and 2 more

Abstract read
In one paragraph

Article in Virologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yibo DingDepartment of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, 221004, China.
Jiajing LiDepartment of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, 3015 GD, the Netherlands.
Xin WangDepartment of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, 3015 GD, the Netherlands.
Simone MalagòPhD National Programme in One Health Approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, 27100, Italy; Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, 37024, Italy.
Amaro Nunes Duarte-NetoDepartamento de Patologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, 05508-000, Brazil.
Xiaohui DingDepartment of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, 221004, China.
Fang QinDepartment of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, 221004, China.
Michela DeianaDepartment of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, 37024, Italy.
Concetta CastillettiDepartment of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, 37024, Italy.
Hongbo GuoDepartment of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, 221004, China. Electronic address: hongbo.guo@xzhmu.edu.cn.
Qiuwei PanDepartment of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, 3015 GD, the Netherlands. Electronic address: q.pan@erasmusmc.nl.
Wenshi WangDepartment of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, 221004, China. Electronic address: wenshi.wang@xzhmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large multi-country outbreak of Oropouche virus (OROV), a segmented negative-sense RNA virus, is emerging in Latin America. By analyzing publicly available whole-genome sequences spanning 1955 to 2024, this study reveals accelerated spatiotemporal evolution of OROV, cooperatively driven by genome mutagenesis and segment reassortment. The strains responsible for the 2023-2024 outbreak are universally reassortants, but form two divergent lineages, namely the Brazil and western Amazon basin lineages. This epidemic spreading is primarily fueled by localized transmission within countries and cross-border spread. Phylogenomic analysis further suggests that the S segment of the viral genome originated in Brazil around the 1740s, underwent diversification into five distinct clusters by the 1970s, and experienced rapid proliferation during 2020-2024. In contrast, the L segment originated in Peru around the 1630s and evolved into two independent clusters by the 1850s. Divergent evolutionary pressures have driven distinct patterns of amino acid changes in viral proteins between the Brazil and the western Amazon basin lineages. These mutations are predicted to alter the protein structures and bear functional consequences for viral fitness and transmission. These findings provide critical insights into the evolutionary dynamics of OROV and underscore the necessity of genome surveillance to track the transmission pathways and spatiotemporal evolution.

Indexed as

Bunyaviridae InfectionsEvolution, MolecularOrthobunyavirusPhylogenyBrazilDisease OutbreaksGenome, ViralHumansReassortant VirusesViral ProteinsWhole Genome SequencingViral ProteinsOropouche virus (OROV)Phylogenomic analysisProtein structureReassortmentSpatiotemporal evolution

Identifiers

PMID41046072
PMCPMC12665425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.